UPDATE : Thursday, August 13, 2020
‘Pseudoephedrine-containing drugs could cause acute skin reaction’  by Lee Hye-seon 2019-01-31 14:34
₩4.7 billion spent on compensation for side effect injuries in 4 years by Lee Hye-seon 2019-01-30 17:18
Government to tighten rule for drug license renewal by Lee Hye-seon 2019-01-29 12:51
Korea to set up new review process for advanced medical devices by Lee Hye-seon 2019-01-28 17:35
4 local firms win exclusive rights to sell Pradaxa’s generic copies by Lee Hye-seon 2019-01-28 11:56
Two CROs reprimanded for delayed reports of adverse events by Lee Hye-seon 2019-01-24 15:40
Court rejects patent registration for acute myeloid leukemia drug Vyxeos by Lee Hye-seon 2019-01-23 14:47
New HIV combo pill Biktarvy approved in Korea by Lee Hye-seon 2019-01-21 15:36
‘Pharmaceuticals need President Moon’s committed support’ by Lee Hye-seon 2019-01-17 17:39
Intra-articular injection Conjuran recognized as new medical tech by Lee Hye-seon 2019-01-15 14:07
Baxter’s dialyzer suspended due to bad-mouthing rival products by Lee Hye-seon 2019-01-15 11:42
5 pharmaceuticals win nod for sustained-release neuropathic pain reliever by Lee Hye-seon 2019-01-14 14:56
14 drugmakers to release generic copies of Stillen 2X in early February by Lee Hye-seon 2019-01-14 11:34
Dongkoo to test stem cell therapy for diabetic foot ulcers by Lee Hye-seon 2019-01-11 15:53
MSD Korea recalls HIV drug Stocrin with particular code by Lee Hye-seon 2019-01-10 11:46
Regulator keeps Kyung Nam Pharm listed with 1-year grace period by Lee Hye-seon 2019-01-09 14:49
Handok and Genexine become largest stakeholder of Rezolute by Lee Hye-seon 2019-01-08 14:53
New influenza drug to be tested in phase-3 trial in Korea by Lee Hye-seon 2019-01-07 15:30
Regulator to nix approval for Lou Gehrig's drug Yoos Neurosolution by Lee Hye-seon 2019-01-07 12:46
5 pharmaceuticals’ growth strategies for 2019 by Lee Hye-seon 2019-01-02 16:25
Back to Top